Where and How to Inject Ozempic: A Comprehensive Guide

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is delivered as a once-weekly subcutaneous injection that activates GLP-1 receptors to reduce appetite and improve blood glucose control. Proper injection technique and site rotation maximize medication effectiveness while minimizing injection-related discomfort and lipohypertrophy—a thickening of fatty tissue that can develop from repeated injections at the same location.

Understanding Semaglutide Injection Sites and Anatomy

Semaglutide is injected into the subcutaneous layer—the fatty tissue just beneath the skin and above muscle. The FDA-approved injection sites are the abdomen, thigh, and upper arm. Each location offers different advantages: the abdomen provides the largest injection area and most consistent absorption, the thigh allows for self-injection visibility and accessibility, and the upper arm works well for those with limited abdominal or thigh tissue. Rotating between these three regions reduces the risk of tissue damage and maintains steady medication absorption over time.

The subcutaneous layer in these areas contains sufficient fatty tissue to accommodate the injection needle safely without contacting muscle or other underlying structures. For patients with lower body fat levels, the abdomen typically remains the preferred site because it tends to have thicker subcutaneous padding. Patients should avoid areas of bruising, hardness, lumps, or inflammation, as these signs indicate damaged or irritated tissue that requires healing before reuse.

Step-by-Step Semaglutide Injection Technique

Begin by washing your hands thoroughly and gathering your injection materials: the semaglutide pen or vial, alcohol swab, and a new needle. Allow the medication to reach room temperature if it has been refrigerated—cold injections can be uncomfortable. Pinch a fold of skin at your chosen injection site using your thumb and forefinger to create a raised area, then insert the needle at a 45-degree angle into the fatty tissue. Press the injection button slowly and steadily, then hold for 3-5 seconds before removing the needle to allow the medication to disperse properly.

After injection, release the pinched skin and gently apply pressure with an alcohol swab for a few seconds if needed. Do not massage the injection area, as this can alter medication absorption. Most patients experience only mild discomfort, described as a slight pinch. If you notice blood or clear fluid leaking from the injection site, apply gentle pressure and note that this typically does not affect medication efficacy. Each needle should be used only once and disposed of in an approved sharps container according to local regulations.

Injection Site Rotation Schedule and Best Practices

A structured rotation pattern prevents tissue damage and maintains consistent drug absorption. A practical schedule involves dividing the abdomen into four quadrants (upper-left, upper-right, lower-left, lower-right) and rotating through them over four weeks, then moving to the thigh for the following four weeks, then the upper arm. This approach ensures each body area receives adequate healing time while keeping injections organized and predictable. Some patients prefer a simpler pattern: abdomen for weeks 1-4, thigh for weeks 5-8, and upper arm for weeks 9-12.

Within each injection site, space needles at least one inch apart from previous injection locations to avoid areas of repeated trauma. Mark or mentally note where you injected last week to ensure adequate spacing. Avoid injecting directly over bones, moles, scars, or areas of existing discomfort. If you notice redness, warmth, or swelling lasting more than a few hours at an injection site, switch to a different location for your next dose and contact your PlexusDx care team if symptoms worsen or persist beyond 48 hours.

Common Injection Concerns and When to Seek Support

Lipohypertrophy—visible thickening or lumping of subcutaneous tissue—is the most common long-term injection complication but is entirely preventable through consistent site rotation. If you notice hard, bumpy, or raised areas at previous injection sites, discontinue injections in that region for at least 4-6 weeks to allow the tissue to remodel. Bruising at the injection site is normal and typically resolves within 7-10 days; applying an ice pack immediately after injection can reduce bruising tendency. Minor bleeding or oozing during injection does not require medical attention unless bleeding is heavy or does not stop within 10 minutes.

Injection anxiety is treatable through gradual exposure and technique refinement. Ensure your hands are steady, inject at a comfortable pace, and consider injecting at a time when you feel relaxed and focused. PlexusDx provides comprehensive injection training materials and 24/7 patient support to address concerns about needle anxiety, site selection, or technique questions. If you develop signs of infection—including increasing redness, warmth, pus, or fever—or experience severe pain unrelated to the injection itself, contact your healthcare provider immediately for evaluation.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot twice?

No—injecting in the same spot repeatedly causes lipohypertrophy, a thickening of fatty tissue that impairs medication absorption. PlexusDx recommends spacing injections at least one inch apart and rotating among abdomen, thigh, and upper arm sites weekly to maintain consistent efficacy and tissue health.

What angle should the needle enter the skin?

A 45-degree angle is standard for subcutaneous semaglutide injection, as it positions the needle tip in the fatty layer beneath skin without contacting muscle. Some patients with thicker subcutaneous tissue may use a 90-degree angle, but 45 degrees minimizes discomfort and reduces the risk of intramuscular injection.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with a flat monthly price across all dose levels—your dose may need to go up, but your price won't. HSA and FSA funds are accepted, and PlexusDx serves all 50 states without requiring insurance or membership fees.

Is bruising after a semaglutide injection normal?

Mild bruising is normal and typically fades within 7-10 days. Ice application immediately after injection reduces bruising tendency. Larger or persistent bruises may indicate you hit a small blood vessel; rotating injection sites and using proper technique minimize this occurrence.

Does the Precision Peptide Genetic Test help with semaglutide response?

Yes—PlexusDx Precision Peptide Genetic Test ($298) analyzes variants in GIPR genes that influence your receptor sensitivity and semaglutide response. This genetic insight helps personalize your treatment plan and guides dose escalation timing for optimal weight loss outcomes.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.